Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction.
Conclusions: HGI in the VVS can be performed safely and can effectively reduce the bladder dose in BT for uterine cervical cancer patients.
PMID: 30911303 [PubMed]
Source: Journal of Contemporary Brachytherapy - Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
More News: Bladder Cancer | Bleeding | Brachytherapy | Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Cervical Cancer | Colorectal Cancer | External Beam Therapy | Radiation Therapy | Statistics | Study